| Study Title |
Completed
|
Status
|
| ASPAC – The Asian-Pacific Study on Coronary Heart Disease Risk Factor Intervention ( Coronary Heart Disease Risk Factors in Patients with Acute Coronary Syndromes in the Asia Pacific Region ) |
2000
|
Completed
|
| CHARM Study – Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity |
2002
|
Completed
|
| ASIA PACIFIC MINICROWN Registry |
2002
|
Completed
|
| A – Z Study – AGGRASTAT to ZOCOR |
2004
|
Completed
|
| DECODE STUDY – A Randomized Study with the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients with Native Coronary Artery Lesions |
2004
|
Completed
|
| ACUTE II – An Randomized, Parallel, Double Blind Safety Study of Enoxaparin VS Unfractopmated Heparin in Tirofiban and Aspirin Treated. |
2004
|
Completed
|
| OVERTURE – Omapatrilat versus Enalapril Randomized Trial of Utility in Reducing Events. |
2004
|
Completed
|
| MICHAELANGELO OASIS 5 – UA / NSTEMI – An international Randomised Double-Blind Study Evaluating the Efficacy and Safety of Fondaparinux versus Enoxaparin In the Acute Treatment of Unstable Angina / Non ST Segment Elevation MI Acute Coronary Syndromes |
2005
|
Completed
|
| MICHAELANGELO OASIS – 6 (STEMI) – An International Randomized Study Evaluating the Efficacy and Safety of Fondaparinux Sodium versus Control Therapy and Glucose-insulin-potassiumInfusion versus Control in Broad Range of Patients with ST Segment Elevation |
2005
|
Completed
|
| ExTRACT – Timi 25 ; A Randomized Double-Blind, Double-Dummy, Parallel Group, Multinational, Clinical Study to Evaluate the Efficacy and Safety of Enoxaparin Versus Unfractionated Heparin in Patients with Acute ST Segment Elevation Myocardial Infarction |
2005
|
Completed
|
| RIVIERA – Registry on Intravenous Anticoagulation in the Elective and Primary Real World of Angioplasty. |
2005
|
Completed
|
| DISCOVERY Trial – An Open-Label Randomised, Multi-Centre, Phase Iiib/IV, Parallel Group Study to Compare the Efficacy and Safety of Rosuvastatin and Atorvastatin in Subjects with Type Iia and Iib Hypercholesterolaemia |
2005
|
Completed
|
| ACCORD Registry – Acute Coronary Syndromes Descriptive Study ACCORD Registry. Evaluation of Compliance with Existing Guideline in Patients with Acute Coronary Syndromes (Unstable Angina and Non-ST elevation Myocardial Infarction. |
2005
|
Completed
|
| Early ACS Trial – Early Glycoprotein IIb/IIIa Inhibition in Non ST Segment Elevation Acute Coronary Syndrome : A randomised, Placebo-Controlled Trial Evaluating the Clinical Benefits of Early Front-loaded Eptifibatide (the cont… refer the progress) |
2007
|
Completed
|
| ADAGIO – A Randomized ,Double-Blind,Two Arms Placebo-Controlled,Parallel,Multicenter Study of Rimonabant 20mg Once Daily in the Treatment of Atherogenic Dyslipidemia in Abdominally Obese Patients. |
2007
|
Completed
|
| E-5 registry – Endeavor Five Registry |
2007
|
Completed
|
| e-Healing Registry – Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth Registry |
2007
|
Completed
|
| TRANSCEND – Telmisartan Randomized Assessment Study in ACE Intolerant |
2008
|
Completed
|
| ONTARGET – Ongoing Telmisartan Alone In Combination With Ramipril Global End Point Trial |
2008
|
Completed
|
| REACH Registry – An International Prospective Observation Registry in Subjects at Risk of Atherothrombotic Events. |
2008
|
Completed
|
| POST MI Study – Open-Labeled Multicentre Study to Assess The Efficacy of Switching to a combination tablet Ezetimibe / Simvastatin 10 mg / 40 mg, Compared to Doubling the Dose of Statin in Patients Hospitalised with a Coronary Event. |
2008
|
Completed
|
| OLYMPIC Registry – Global Taxus Libert’e Registry Programme to Support Worlwide Commercialisation |
2008
|
Completed
|
| INSPIRE ME / IAA |
2008
|
Completed
|
| ATHENA – A Placebo-Controlled, Double Blind, Parallel Arm Trial to Assess the Efficacy of Dronedarone 400 mg Bid for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in Patients with Atrial Fibrillation/Atrial Flutter (AF/AL). |
2008
|
Completed
|
| IDMPS – International Diabetic Management Practice Study |
2008
|
Completed
|
| HEAAL – A Multicenter,Double-Blind Randomized,Parallel Group Study to Evaluate the Effects of Two Different Doses of Losartan on Morbidity and Mortality in Patients with Symptomatic Heart Failure Intolerant of ACE Inhibitor Treatment. |
2009
|
Completed
|
| ACTIVE – Atrial Fibrillation Clopidogrel Trial with Irbesatan for Prevention of Cardiovascular Events |
2009
|
Completed
|
| RE-LY STUDY – Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) Comparing the Efficacy and Safety of Two Blinded Doses of Dabigatran Etexilate with Open Label Warfarin for the Prevention of Stroke and Systemic Embolism in Patients with |
2009
|
Completed
|
| PLATO – A Study of Platelet Inhibition and Patient Outcomes;A Randomized,Double-Blind,Parallel Group,Phase 3,Efficacy and Safety of AZD6140 Compared with Clopidogrel for Prevention of Vascular Events in Patients with Non-ST or ST Elevation Acute Coronary Syndrome (ACS) |
2009
|
Completed
|
| CRESCENDO – Randomized, Multinational, Multicenter, Double-Blind Placebo-Controlled, Two Arm Parallel Group Trial of rimonabant 20 mg OD for Reducing the Risk of Major Cardiovascular Events in Abdominally Obese Patients with Clustering Risk Factors. |
2009
|
Completed
|
| SEPIA ACS1 – A Randomised, Double-Blind, Triple-Dummy, Dose-Ranging Study, Including an Active Control of Unfractionated Heparin and Eptifibatide, (Cont. Below) |
2009
|
Completed
|
| CURRENT/OASIS 7 – Randomized, Multinational, Double-Blind Study, Comparing a High Loading Dose Regimen of Clopidogrel Versus Standard Dose in Patients With Unstable Angina or Non-ST Segment Elevation Myocardial Infarction Managed with an Early Invasive Strategy |
2009
|
Completed
|
| IMAGE IoproMide (Ultravist®) – To Gain further Information on Tolerability and Safety in X-Ray Examination |
2009
|
Completed
|
| ASCEND-HF – Acute Study of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure |
2009
|
Completed
|
| CLARINET – International Randomized Double Blind Study Evaluating the Efficacy and Safety of Clopidogrel 0.2 mg/kg Once Daily Versus Placebo |
2009
|
Completed
|
| DOT-HF – Diagnostic Outcome Trial in Heart Failure |
2009
|
Completed
|
| S9 Stent – Physician Assessment of the Medtronic S9 Bare Metal Stent Utilized for Treatment of Coronary Occlusive Disease |
2010
|
Completed
|
| PRIMULA – Prevalence, Treatment Patterns & Resource use in Patient with Mixed Dyslipidemia Using Lipid Lowering Agents |
2010
|
Completed
|
| SPIRIT V – A Clinical Evaluation of the XIENCETM V Everolimus Eluting Coronary Stent System in the Treatment of Patients with Native Coronary Artery Lesions. |
2010
|
Completed
|
| SPIRIT V (Diabetic) – A Clinical Evaluation of the XIENCETM V Everolimus Eluting Coronary Stent System in the Treatment of Patients with Native Coronary Artery Lesions. (Diabetic Patient) |
2010
|
Completed
|
| Rocket AF – A Prospective, Randomized, Double-Blind, Double-Dummy, Parallel-Group, Multicentre, Event-Driven, Non-Inferiority Study Comparing the Efficacy and Safety of Once-Daily Oral Rivaroxaban (Bay 597939) with Adjusted-Dose Oral Warfarin for ths Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Subjects with Non-Valvular Atrial Fibrillation (Protocol No: 150-CL-030) |
2010
|
Completed
|
| Q-SYMBIO – Coenzyme Q10 s Adjunctive Treatment of Chronic Heart Failure. |
2010
|
Completed
|
| CARE II – A Prospective, Randomized, Multicenter Study to Evaluate the Safety, Efficacy, and Performance of the CardioMind Coronary Stent Systems for Treatment of Stenotic Lesions |
2010
|
Completed
|
| PLATINUM QCA – A Prospective, Multi-center Trial to Assess an Everolimus-Eluting Coronary Stent System – PROMUS ELEMENT TM |
2010
|
Completed
|
| TRACER – A Multicenter ,Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects With Coronary Syndrome: Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome |
2010
|
Completed
|
| ASSERT – Device-Detected Atrial High RateEpisodes-Asymptomatic AF & Stroke Evaluation in Pacemaker Patient &the AF Reduction Atrial Pacing Trial |
2010
|
Completed
|
| SHIFT – Effects of Ivabradine on Cardiovascular Events in Patients with Moderate to Severe Chronic Heart Failure and Left Ventricular Systolic Dysfunction. A Three-Year Randomised Double-Blind Placebo-Controlled International Multicentre Study |
2010
|
Completed
|
| REVATIO – Multinational, Multicentre, Randomized,Parallel Group,Double-Blind Study to Assess the Efficacy and Safety of 1mg , 5 mg and 20 mg TID of Oral Sildenafil in the Treatment of Subjects Aged 18 Years and Over with Pulmonary Arterial Hypertension |
2011
|
Completed
|
| SAFE – Septal Pacing for Atrial Fibrillation Suppression Evaluation Atherothrombotic Events |
2011
|
Completed
|
| PACE – Pacing to Avoid Cardiac Enlargement |
2011
|
Completed
|
| E-Select |
2011
|
Completed
|
| Record AF-AP – Registry on Cardiac Rhythm Disorder: An International ,Observational, Prospective Survey Assessing the Control of Atrial Fibrillation in Asia Pacific. |
2011
|
Completed
|
| Medtronic Attain Success Clinical Trial |
2011
|
Completed
|
| TRA2P – A Multicenter, Randomized, Double-blind,Placebo-controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects With a History of Atherosclerotic Disease: Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events ( TRA 2°P –TIMI 50) ( Protocol Number.P04737) |
2012
|
Completed
|
| SERAPHIN ( DOUBLE-BLIND) – Study with Endothelin Receptor Antagonist in Pulmonary Arterial Hypertension to Improve Clinical Outcome |
2012
|
Completed
|
| The PEPCAD IV DM Pilot Study – Paclitaxel-Eluting Balloon Angioplasty and Cobalt-Chromium Stents Versus Conventional Angioplasty and Paclitaxel-Eluting Stents in the Treatment of Native Coronary Artery Stenoses of Diabetic Patients. |
2012
|
Completed
|
| RELY ABLE – Multi-Centre Long Term Open Label Follow-Up Treatment of Patients with Non-Valvular Atrial Fibrillation Who Have Been Previously Treated with Dabigatran or Warfarin in the RE-LY Trial and a Cluster Randomised Trial to Assess the Effect of a Knowledge Translation Intervation on the Patient’s Prognosis,Cardiovascular Risk Profile and Quality of Atrial Fibrillation Management , As Compared to General Information on Best Evidence Based Medicine |
2012
|
Completed
|
| TRILOGY ACS – Lilly Protocol H7T-MC_TABY – A Comparison of Prasugrel and Clopidogrel in Subjects with Unstable Angina / NSTEMI Acute Coronary Syndrome who are Medically Manage. |
2012
|
Completed
|
| V710 – A Randomized, Multicenter, Double-Blind, Group-Sequential Study to Evaluate the Efficacy, Immunogenicity, and Safety of a Single Dose of Merck 0657nl Staphylococcus Aureus Vaccine (V710) in Adult Patients Schedule for Cardiothoracic Surgery. |
2012
|
Completed
|
| EXAMINE – A Multicenter,Randomized,Double-Blind,Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment with Alogliptin in Addition to Standard of Care in Subjects with Type 2 Diabetes and Acute Coronary Syndrome. |
2013
|
Completed
|
| CONTRAST – Combined N-Acetylcysteine and Bicarbonate in PCI To Reduce Adverse Side Effect of Contrast |
2013
|
Completed
|
| IMPROVE IT – A Multicenter Double-Blind Randomized Study to Establish the Clinical Benefit & Safety of Vytorin (Ezetimibe /Simvastatin Tab) vs Simvastatin Monotherapy in High Risk Subjects Presenting with ACS (Improved reduction of outcomes: Vytorin Efficacy Inter. Trial) |
2014
|
Completed
|
| PROTECT – Patient Related Outcomes with Endeavor Versus Cypher Stenting Trial |
2014
|
Completed
|
| SIGNIFY – Study (Effects of Ivabradine in Patients with Stable Coronary Artery Disease without Clinical Heart Failure). |
2014
|
Completed
|
| Pain Free SST CLINICAL STUDY |
2014
|
Completed
|
| IVORY – Ingenio Device Algorithm Study |
2014
|
Completed
|
| MIRACLE EF TRIAL |
2014
|
Completed
|
| TRICS II – Transfusion Requirements in Cardiac Surgery |
2014
|
Completed
|
| ALECARDIO – Study (T2D) Cardiovascular Outcomes Study to Evaluate the Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients with A Recent Acute Coronary Syndrome (ACS) Event and Type 2 Diabetes Mellitus |
2014
|
Completed
|
| PLATINUM WH – A Prospective , Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent S( PROMUS ElementTM) for the Treatment of Up to Two De Novo Coronary Artery Lesions |
2015
|
Completed
|
| GRIPHON Study – A Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study to Demonstrate the Efficacy and Safety of ACT-293987 in Patients with Pulmonary Arterial Hypertension |
2015
|
Completed
|
| SIMPLE – Shockless Implant Evaluation. A Prospective Randomized Clinical Study |
2015
|
Completed
|
| Attain Performa – Medtronic Attain® PerformaTM Quadripolar Lead Clinical Study |
2015
|
Completed
|
| Model 20066 LV Lead Study |
2015
|
Completed
|
| ABSORB FIRST REGISTRY |
2015
|
Completed
|
| CL3-16257-098 – Safety of Oral Chronic Administration of Ivabradine Modified Release Formulation Compared to Ivabradine Immediate Release Formulation in Patients with Chronic Heart Failure and Left Ventricular Systolic Dysfunction. A 6 to 12 months Randomised Double Blind Parallel Groups Multicentre Study. |
2015
|
Completed
|
| MultiSENSE – Multisensor Chronic Evaluations in Ambulatory Heart Failure Patients |
2015
|
Completed
|
| ABSORB EXTEND – A Continuation in the Clinical Evaluation of the Abbott Vascular Everolimus-Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with De Novo Native Coronary Artery Lesions |
2015
|
Completed
|
| CLARIFY – Prospective Observational Longitudinal Registry of Patients with Stable Coronary Artery Disease |
2015
|
Completed
|
| CRT MPP – More Response on Cardiac Resynchronization Therapy (CRT) with MultiPoint Pacing (MPP) |
2015
|
Completed
|
| STICH – Surgical Treatment for Ischemic Heart Failure |
2016
|
Completed
|
| REMEDEE – A Prospective ,Randomized Study to Evaluate the Safety and Effectiveness of an AbluMinal Sirolimus CoatED Bio-Engineered StEnt ( Combo Bio-Engineered Sirolimus Eluting Stent) Compared with TAXUSR LiberteR Stent Control Arm for Treatment of Stenotic Lesions in Native Coronary Arteries |
2016
|
Completed
|
| RESOLUTE Asia – A Prospective, Multicenter, Non-randomized Study, Evaluation of the Endeavor Resolute Zotarolimus-Eluting Coronary Stent System in a Patient Population with Long Lesion(s) and/or Dual Vessels in Asia |
2016
|
Completed
|
| A Randomized , Multicenter Study to Evaluate Cardiovascular Outcomes with ITCA 650 in patients Treated with standard of Care for Type 2 Diabetes |
2016
|
Completed
|
| MICRA Transcatheter Pacing Study |
2016
|
Completed
|
| Leaders Free – A Prospective Randomized Comparison of the BioFreedomTM Biolomus A9TM Drug coated Stent Versus the GazelleTM Bare Metal Stent in Patients at High Risk for Bleeding |
2016
|
Completed
|
| TRIUS – A Phase 3 Randomized Double-blind Study Comparing TR-701 FA and Linezolid in Ventilated Gram-positive Nosocomial Pneumonia |
2016
|
Completed
|
| MAESTRO DB – A Multi-Center, Double-Blind, Randomized, Placebo- Controlled, Parallel-Group, Phase 3 Study to Evaluate the Effects of Macitentan on Exercise Capacity Subjects with Eisenmenger Syndrome- Protocol number: AC-055-305 |
2017
|
Completed
|
| QUALIFY REGISTRY – Quality of Adherence to Guideline Recommendations for Life-Saving Treatment in Heart Failure: an International Survey |
2017
|
Completed
|
| FOURIER – A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Assessing the Impact of Additional LDL-Cholesterol Reduction on Major Cardiovascular Events When AMG 145 is Used in Combination with Statin Therapy in Patients with Clinically Evident Cardiovascular Disease. |
2017
|
Completed
|
| Relax Asia – A multicenter, Randomized, Double-Blind, Placebo Controlled Phase III Study Efficacy, to Evaluate the Safety and Tolerability of Serelaxin when Added To Standard Therapy in Acute Heart Failure Patients |
2017
|
Completed
|
| MODIFY – Effects of Ivabradine on Plaque Burden, Morphology and Composition in Patients with Clinically Indicated Coronary Angiography. A Randomised Double-Blind Placebo-controlled International Multicentre Study |
|
Completed
|
| SERAPHIN ( Open Label) – Study With Endothelin Receptor Antagonist in Pulmonary Arterial Hypertension to Improve Clinical Outcome |
2018
|
Completed
|
| PARADIGM-HF Open Label – A Multicenter, Randomized, Double-Blind, Parallel Group, Active-Controlled Study to Evaluate the Efficacy and Safey of LCZ696 Compared to Enalapril on Morbidity and Mortality in Patients With Chronic Heart Failure and Reduced Ejection Fraction. |
2018
|
Completed
|
| NIS RELATE – A Study Where the Medicinal Product(s) is (are) Prescribed in the Usual Manner in Accordance With the Terms of the Marketing Authorization. The Assignment of the Patient to a Particular Therapeutic Strategy is Not Decided in Advance by a Trial Protocol But Falls Within the Current Practice and the Prescription of the Medicine is Clearly Separated From the Decision to Include the Patient in the Study. No Additional Diagnostic or Monitoring Procedures Shall be Applied to the Patients and Epidemiological Methods Shall be Used for the Analysis of the CollectedData |
2018
|
Completed
|
| MASCOT REGISTRY – Multinational Abluminal Sirolimus Coated Bio-Engineered Stent |
2018
|
Completed
|
| COROFLEX ISAR INTERNATIONAL REGISTRY |
2018
|
Completed
|
| TRICS III – Transfusion Requirements in Cardiac Surgery |
2018
|
Completed
|
